← Back to Clinical Trials
Recruiting NCT07088302
Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates
Trial Parameters
Condition Premature
Sponsor Alexandria University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 3 Days
Max Age 1 Month
Start Date 2025-08-30
Completion 2026-02-28
All Conditions
Interventions
lactase administrationplacebo
Brief Summary
This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.
Eligibility Criteria
Inclusion criteria will be as follows: * Preterm neonates ≤ 32 weeks gestational age. * Start feeding in the first 72 hours of life. 8. Exclusion criteria Patients with any of the following will be excluded: 1. Parental consent lacking/refusal. 2. Obvious major congenital abnormalities. 3. Infants more than 72 hours of age at the time of randomization. 4. Delayed introduction of feeding (beyond three days of life). 5. Known galactosemia. 6. Severe IUGR. -